On-demand virtual event
Biological & Medicinal Chemistry
A new wave of drugs that achieve the targeted delivery of radioisotopes are rapidly gaining momentum and attracting significant excitement. As the discovery and development pipeline widens, and new drug approvals increase, the field is expanding and becoming more diverse in the strategies employed to deliver the cell-killing radioisotopes.
One area that is showing considerable promise is the incorporation of an isotope-chelating moiety into a peptide ligand for a cell surface receptor on the cancer cells of interest. In this webinar we will discuss strategies for the discovery and optimisation of new peptide ligands for such targets, as well as their synthesis, investigation of efficacy, metabolism and distribution, and ultimately their manufacture.
Jiazhi Liu
Associate Director, WuXi AppTec
Shaowei Wang
Assistant Director, Molecular Imaging Center
Alex Satz
Executive Director, Head of WuXi Biology DB Europe, WuXi AppTec
Dave Madge
VP, Discovery Services
Keep learning. Excel in your career.
Choose from more than 200 courses in seven different categories, taught by experts in the chemistry community, online and in person.